InsiderTrades.com logo
The Best AI Stock to Own in the World Today is Trading for Just $25
From Banyan Hill Publishing   |   Ad
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
See how you can invest alongside him

Terrence Kearney Biography and Net Worth

Director of Acceleron Pharma
  • Phone
  • Email
  • Website


Terrence Kearney has more than three decades of global healthcare experience at major pharmaceutical and life sciences companies.Most recently,Kearney served on the executive management team for Hospira, Inc. where he held the role of Chief Operating Officer from 2006 through 2011 and Chief Financial Officer from 2004 to 2006.

In theseroles,Kearney had broad responsibility for the company’s global operations, including commercial, manufacturing and research and development activities, and financial management strategies.Prior to Hospira,Kearney spent 25 years at Abbott Laboratories in various financial management roles, including Vice President and Treasurer.
Kearney earned a Bachelor’s degree in Biology from the University of Illinois and a Master’s in Business Administration from the University of Denver.Kearney serves as Chair of the Audit Committee and member of the Management Development and Compensation Committee for Vertex Pharmaceuticals.

What is Terrence C. Kearney's net worth?

The estimated net worth of Terrence C. Kearney is at least $4.49 million as of October 12th, 2020. Mr. Kearney owns 25,127 shares of Acceleron Pharma stock worth more than $4,491,451 as of April 29th. This net worth estimate does not reflect any other investments that Mr. Kearney may own. Learn More about Terrence C. Kearney's net worth.

How do I contact Terrence C. Kearney?

The corporate mailing address for Mr. Kearney and other Acceleron Pharma executives is 128 SYDNEY STREET, CAMBRIDGE MA, 02139. Acceleron Pharma can also be reached via phone at (617) 649-9200 and via email at [email protected]. Learn More on Terrence C. Kearney's contact information.

Has Terrence C. Kearney been buying or selling shares of Acceleron Pharma?

Terrence C. Kearney has not been actively trading shares of Acceleron Pharma during the last quarter. Most recently, Terrence C. Kearney sold 37,500 shares of the business's stock in a transaction on Monday, October 12th. The shares were sold at an average price of $119.36, for a transaction totalling $4,476,000.00. Following the completion of the sale, the director now directly owns 25,127 shares of the company's stock, valued at $2,999,158.72. Learn More on Terrence C. Kearney's trading history.

Who are Acceleron Pharma's active insiders?

Acceleron Pharma's insider roster includes Habib Dable (CEO), Sujay Kango (EVP), Terrence Kearney (Director), Thomas McCourt (Director), Kevin McLaughlin (CFO), Adam Veness (SVP), and Joseph Zakrzewski (Director). Learn More on Acceleron Pharma's active insiders.

Terrence C. Kearney Insider Trading History at Acceleron Pharma

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/12/2020Sell37,500$119.36$4,476,000.0025,127View SEC Filing Icon  
See Full Table

Terrence C. Kearney Buying and Selling Activity at Acceleron Pharma

This chart shows Terrence C Kearney's buying and selling at Acceleron Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Acceleron Pharma Company Overview

Acceleron Pharma logo
Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA.
Read More

Today's Range

Now: $178.75
Low: $178.75
High: $178.75

50 Day Range

MA: $176.25
Low: $172.08
High: $179.68

2 Week Range

Now: $178.75
Low: $108.82
High: $189.99

Volume

N/A

Average Volume

572,759 shs

Market Capitalization

$10.93 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.13
The Best AI Stock to Own in the World Today is Trading for Just $25
From Banyan Hill Publishing   |   Ad
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
See how you can invest alongside him